<DOC>
	<DOCNO>NCT01813552</DOCNO>
	<brief_summary>This study design evaluate potential effect Ritonavir ( Norvir® ) omeprazole ( Prilosec® ) pharmacokinetics samatasvir assess safety tolerability study drug administer alone combination healthy participant .</brief_summary>
	<brief_title>To Evaluate Effect Ritonavir Omeprazole Pharmacokinetics Samatasvir ( IDX719 ) Healthy Participants ( MK-1894-006 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Read sign write informed consent form ( ICF ) nature study fully explain . All participant childbearing potential must agree use double method birth control ( one must barrier ) Screening least 90 day last dose study drug . Pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>HCV</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>antiviral drug</keyword>
	<keyword>liver</keyword>
</DOC>